Vultr, the large, privately-held cloud computing platform, today announced that Athos Therapeutics, Inc. (“Athos”), a clinical-stage biotechnology company, has chosen Vultr Cloud GPU to run its AI model training, tuning, and inference. Powered by NVIDIA HGX H100 systems and running on Dell Technologies’ PowerEdge XE9680 servers, Vultr now offers Athos the needed security and confidentiality for their intellectual property, omics data, and proprietary AI algorithms.
AI-based Small Molecule Therapeutics Pioneer Athos Therapeutics Selects Vultr for Secure AI Training in the Cloud
June 18, 2024 by
Livermore Lab and BridgeBio Announce Human Trials for HPC-Discovered Cancer Drug
June 6, 2024 by
In what Lawrence Livermore National Lab said is “a substantial milestone for supercomputing-aided drug design,” LLNL and BridgeBio Oncology Therapeutics today announced clinical trials have begun for ….
